Whole-Brain Radiotherapy Shows No Survival Benefit over Targeted Radiotherapy for Patients with Limited Brain Tumor Metastases
PHILADELPHIA (September 26, 2016) – Thomas M. Churilla, MD, a resident physician at Fox Chase Cancer Center, presented the results of a secondary analysis of a prospective randomized trial at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting.